m+Medelevator.RU
← Поиск публикаций
Cellular immunology · 2026

Single-cell study reveals early alterations in peripheral blood immune responses at day 7 following microwave ablation for lung cancer.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Wu Yuesong, Wei Xiaolong, Yang Wentao, Wang Fengping, Wang Jianchun, Huang Zhi, Zou Fengxiang, Liu Jianqun

Аннотация

BACKGROUND: Lung cancer (LC) is a leading cause of cancer-related death. Microwave ablation (MWA) is a promising local therapy, but its impact on systemic immunity remains unclear.

METHODS: In this exploratory pilot study, paired peripheral blood samples from two LC patients pre- and post-MWA were analyzed by single-cell RNA sequencing (scRNA-seq). Cell composition, functional states, and intercellular communication were investigated. The expression levels of cytotoxic factors including GZMB, TNF-α, and IFN-γ in CD8+ T cells derived from PBMCs were determined via RT-qPCR and ELISA assays.

RESULTS: scRNA-seq identified 9 immune cell types. Post-MWA, monocytes and NKT cells increased. Functional changes included enhanced T cell cytotoxicity, activated pro-inflammatory monocytes, and anti-tumor neutrophil differentiation. Cell communication analysis highlighted enriched LGALS9-CD45 and RETN-CAP1 interactions between T cells and monocytes/neutrophils. In vitro cellular assays revealed that the expression of cytotoxic factors (GZMB, TNF-α, and IFN-γ) in CD8+ T cells was significantly upregulated following MWA treatment.

CONCLUSION: This pilot study provides preliminary single-cell evidence suggesting how MWA remodels the immune landscape in LC, however, these findings require further validation in larger cohorts.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты